China's E-cigarette Export Data to Indonesia in April 2024

Industry Insight by 2FIRSTS

Jun.18.2024

China's E-cigarette Export Data to Indonesia in April 2024

China's e-cigarette exports to Indonesia in April 2024 reached $8.65 million, up 2.54% monthly but down 28.44% yearly.

According to updated trade data from the General Administration of Customs of China, 2FIRSTS has compiled e-cigarette export data from China to Indonesia in April 2024. The specifics are as follows:

The export value was around 8.65 million US dollars, an increase of 2.54% compared to the previous period, but a decrease of 28.44% compared to the same period last year.

The export volume is about 105 tons, a decrease of 10.22% compared to the previous period and a decrease of 40.06% year-on-year.

The export unit price is $82.52 per kilogram, which is an increase of 14.2% compared to the previous period and a 19.4% increase year-on-year; The average price for "e-cigarettes and similar personal electronic vapor devices" is $16.06 per unit.

Among them, 'e-cigarettes and similar personal electronic vaporizing devices' accounted for 85.8% of the export categories, while 'non-smoking or reconstituted tobacco, nicotine-containing non-combustible products' accounted for 14.2%.

Also Read:

[1] China's April 2024 E-cigarette Exports to Spain Data Analysis

[2] Trade Data: China's E-cigarette Exports to South Africa in April 2024

[3] Trade Summary: E-cigarette Exports from China to New Zealand (April 2024)

[4] Analysis of China's E-cigarette Exports to Belgium in April 2024

[5] Analysis of China's E-cigarette Export Data to France, April 2024

[6] Chinese E-cigarette Export to Poland in April 2024 Data

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency

The U.S. FDA has announced the agency-wide deployment of new agentic AI capabilities, providing all employees with an optional multi-step task automation tool. Building on the broad adoption of its earlier large-language-model system, Elsa, the FDA aims to use this next-generation AI workflow to accelerate product review, regulatory oversight, and internal operations, while maintaining strict human supervision and data security.

Dec.02 by 2FIRSTS.ai

The Spanish Nicotine Pouches Association (ABN) is officially launched, calling for a clear regulatory framework grounded in scientific evidence

The Spanish Nicotine Pouches Association (ABN) has launched in Madrid, uniting more than 40 companies to call for science-based, proportionate regulation. The group warns that a proposed 0.99 mg nicotine cap could amount to a de facto ban and introduces new voluntary industry standards in response.

Dec.03

WHO Chief Warns of E-Cigarette Threat to Youth as COP11 Opens in Geneva

More than 1,400 delegates from 162 Parties convened in Geneva on November 17 for the Eleventh Session of the Conference of the Parties (COP11) to the WHO Framework Convention on Tobacco Control (WHO FCTC). WHO Director-General Tedros Adhanom Ghebreyesus opened the session with a stark warning: tobacco and nicotine companies are targeting schools as the “new front line” to recruit a generation of addicts through e-cigarettes and nicotine pouches.

Nov.18 by 2FIRSTS.ai

NYC Reaches Settlement with E-Cigarette Distributors in Flavored Vape Crackdown

New York City has reached settlement agreements with two e-cigarette wholesalers accused of selling flavored vapes illegally. The companies agreed to stop all flavored vape transactions in the city and face $1,000 fines for future violations. Litigation against other defendants in the broader case continues.